Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis

NCT02696031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

555

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-radiographic Spondyloarthritis

Interventions

DRUG: Secukinumab
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals